[8-K] Nutex Health, Inc. Reports Material Event

Rhea-AI Filing Summary

Nutex Health Inc. reported that it has announced its financial and operating results for the second quarter ended June 30, 2025. The company is sharing these results through a press release dated November 18, 2025, which is furnished as Exhibit 99.1. The company states that this results information, including the exhibit, is being furnished rather than filed under securities laws and will only be incorporated into other documents if expressly stated there.

0001479681FALSE00014796812025-11-182025-11-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) November 18, 2025

NUTEX HEALTH INC.

(Exact name of registrant as specified in its charter)

Delaware			001-41346			11-3363609
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(I.R.S. Employer Identification Number)

6030 S. Rice Ave, Suite C, Houston, Texas 77081

(Address of principal executive offices) (zip code)

(713) 660-0557

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Precommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Precommencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbols(s)			Name of each exchange on which registered
Common Stock, $0.001 par value			NUTX			NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 2.02. Results of Operations and Financial Condition

On November 18, 2025, Nutex Health Inc. (the “Company”) announced its financial and operating results for the second quarter ending June 30, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits

(d)Exhibits

Exhibit No.			Description of Exhibit
99.1			Press Release dated November 14, 2025
104			Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

THE INFORMATION CONTAINED IN ITEM 2.02 OF THIS CURRENT REPORT, INCLUDING EXHIBIT 99.1 ATTACHED HERETO, SHALL NOT BE DEEMED “FILED” FOR THE PURPOSES OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, NOR SHALL IT BE DEEMED INCORPORATED BY REFERENCE INTO ANY REGISTRATION STATEMENT OR OTHER FILING PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, EXCEPT AS OTHERWISE EXPRESSLY STATED IN SUCH FILING

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 18, 2025

Nutex Health Inc.

By: /s/ Jon C. Bates

Jon C. Bates

Chief Financial Officer

FAQ

What did Nutex Health (NUTX) announce in this 8-K?

Nutex Health Inc. announced that it has released its financial and operating results for the second quarter ended June 30, 2025, via a press release furnished with the report.

Which period do the Nutex Health (NUTX) results cover?

The results announced by Nutex Health cover the second quarter ended June 30, 2025.

Where can investors find the detailed Q2 2025 results for Nutex Health (NUTX)?

Detailed Q2 2025 results are provided in the company’s press release furnished as Exhibit 99.1 to this report.

How is the Nutex Health (NUTX) Q2 2025 results information treated under securities laws?

The company states that the information in Item 2.02, including Exhibit 99.1, is furnished and not deemed filed for purposes of the Securities Exchange Act of 1934.

Who signed the Nutex Health (NUTX) report announcing Q2 2025 results?

The report was signed on behalf of Nutex Health Inc. by Jon C. Bates, the company’s Chief Financial Officer.

What exhibits are included with this Nutex Health (NUTX) 8-K?

The report includes Exhibit 99.1, the press release dated November 18, 2025, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.